Recently Viewed
Clear AllValue Research Rating
Quality Score 
0/0
Growth Score
0/0
Valuation Score
0/0
Momentum Score
0/0
Today’s Range
52 Week Range
Liquidity
Market cap
₹3,894 Cr
Revenue (TTM)
₹1,497 Cr
Net Profit (TTM)
₹132 Cr
ROE
14.3 %
ROCE
14.6 %
P/E Ratio
29.4
P/B Ratio
3.7
Industry P/E
46.68
EV/EBITDA
17.8
Div. Yield
0 %
Debt to Equity
0.4
Book Value
₹185.8
EPS
₹23.1
Face value
10
Shares outstanding
57,224,929
CFO
₹408.57 Cr
EBITDA
₹696.48 Cr
Net Profit
₹436.77 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Innova Captab
| -5.6 | 0.7 | -1.4 | -22.6 | -- | -- | -- |
|
BSE Healthcare
| -2.6 | -1.7 | -3.7 | 3.2 | 25.2 | 15.5 | 10.7 |
|
Company
|
2025
|
2024
|
|---|---|---|
|
Innova Captab
| -35.1 | 110.3 |
|
BSE Small Cap
| -6.6 | 29.0 |
|
BSE Healthcare
| -3.3 | 43.1 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Innova Captab
|
679.6 | 3,893.6 | 1,497.0 | 132.4 | 11.9 | 13.4 | 29.4 | 3.7 |
| 2,399.8 | 19,696.6 | 1,215.1 | 284.8 | 28.7 | 21.1 | 68.6 | 13.0 | |
| 677.3 | 13,308.3 | 7,266.8 | 627.5 | 11.9 | 12.6 | 21.2 | 2.4 | |
| 591.0 | 14,639.8 | 5,092.5 | 545.5 | 15.9 | 14.1 | 26.8 | 3.5 | |
| 831.4 | 13,249.0 | 7,918.4 | 429.9 | 10.7 | 7.2 | 30.6 | 2.0 | |
| 959.2 | 17,156.0 | 4,560.2 | 1,544.6 | 35.1 | 19.2 | 11 | 2.0 | |
| 1,456.4 | 16,762.8 | 1,419.3 | 20.1 | 8.4 | 0.5 | 833.9 | 2.9 | |
| 138.4 | 18,376.9 | 8,871.4 | -223.5 | 1.9 | -1.6 | -- | 2.3 | |
| 414.8 | 16,707.9 | 3,720.2 | 352.1 | 13.7 | 8.2 | 47.5 | 3.5 | |
| 1,176.2 | 19,123.7 | 3,151.0 | -10.0 | 8.4 | 2.5 | 869.3 | 4.1 |
5 min read•By Vishal Goyal
Innova Captab Limited, an integrated pharmaceutical company, engages in the research and development, manufacture, distribution, and marketing of drugs in India and internationally. The company provides contract development and manufacturing... organization services to Indian pharmaceutical companies. It is also involved in the development, manufacture, and distribution of generic formulation products, including cephalosporins, proton pump inhibitor, anticholinergic and heparin NSAIDs, analgesics and antipyretic, anticold and antiallergic, antiemetic, antidiabetic, antispasmodic, antifibrinolytic, cardiovascular, antioxidant and vitamins, antihyperuricemia and antigout, fluoroquinolone and macrolide, nootropics and neurotonics/neurotrophics, antiulcerative, antimalarial, erectile dysfunction, anxiolytic, anticonvulsant and antipsychotic, bladder and prostate disorder, antifungal, anthelmintic and antiviral, anticholinergic, anti-asthmatic, and bronchodilator products in the form of tablets, capsules, dry syrups, dry powder injection, ointments, and liquid orals. The company sells its branded generic products through its network of distributors and pharmacies, as well as online through various e-commerce pharmacy sites. Innova Captab Limited was incorporated in 2005 and is based in Panchkula, India. Read more
Incorporated
2005
Chairman
Manoj Kumar Lohariwala
Managing Director
Vinay Kumar Lohariwala
Headquarters
Navi Mumbai, Maharashtra
Website
Looking for more details about Innova Captab Ltd’s IPO? Explore our IPO Details page.
Our rating system has guided millions of investors in the past 20 years.
The share price of Innova Captab Ltd is ₹679.60 (NSE) and ₹680.40 (BSE) as of 20-Mar-2026 IST. Innova Captab Ltd has given a return of -22.6% in the last 1 years.
The P/E ratio of Innova Captab Ltd is 29.41 times as on 20-Mar-2026, a 37 discount to its peers’ median range of 46.68 times.
The P/B ratio of Innova Captab Ltd is 3.66 times as on 20-Mar-2026, a 22 premium to its peers’ median range of 3.00 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
39.15
|
5.23
|
|
2024
|
27.18
|
3.09
|
|
2023
|
0.00
|
0.00
|
|
2022
|
0.00
|
0.00
|
|
2021
|
0.00
|
0.00
|
The 52-week high and low of Innova Captab Ltd are Rs 1,020.70 and Rs 622.00 as of 21-Mar-2026.
Innova Captab Ltd has a market capitalisation of ₹ 3,894 Cr as on 20-Mar-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Innova Captab Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
₹1.05
(
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.